European Archives - Page 767 of 996 - European Medical Journal

EMJ

ESC 2017 – Opening Ceremony

Our full congress review of ESC 2017 will be available soon for free in our Cardiology 5.1 eJournal, but here is a look at the opening ceremony while you…

EMJ

ESC 2017 – Congress Highlights

Here is a look at this year’s congress highlights, and grab our full congress review of ESC 2017 in EMJ’s Cardiology 5.1 eJournal, coming soon.

Innovative Gene Therapy for Duchenne Muscular Dystrophy

INJECTED microdystrophin restores muscle strength and clinical symptoms in dogs with Duchenne muscular dystrophy, according to new research. This…

Nanotechnology Device Transforms Skin Cells into Any Organ

GROUNDBREAKING research by an American team has revealed a successful method of restoring damaged organs using a single small chip. This breakthrough in…

ESHRE 2017 – Interview – Dr Arianna D’Angelo

An interview with Dr Arianna D’Angelo (Fertility Institute-Cardiff University, UK) at this year’s ESHRE congress held in Geneva, Switzerland.

Kidney Graft Survival Unaffected by Donor Age

GRAFT SURVIVAL rate of a transplanted kidney is similar for kidneys from both donors aged >80 years and donors ≤60 years of age, according to…

Kidney Function Decline Linked to Atrial Fibrillation Risk

DECREASED kidney function is associated with a greater chance of atrial fibrillation development, new research suggests. Due to the poor clinical outcome…

Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017

Hamburg, Germany, 08 September, 2017 – Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA)…

Congenica’s Sapientia™ Selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project

Cambridge, UK, 06 September, 2017 – Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership…

AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round

Geneva, Switzerland, 05 September, 2017 – AMAL Therapeutics (AMAL), the Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, today…